4-((6-Chloropyrazin-2-yl)methyl)-1-(methylsulfonyl)azepane

Catalog No.: 
ACQQMC199
CAS No.: 
1316222-91-9
Molecular Formula: 
C12H18ClN3O2S
Molecular Weight: 
303.82
4-((6-Chloropyrazin-2-yl)methyl)-1-(methylsulfonyl)azepane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$693.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((6-Chloropyrazin-2-yl)methyl)-1-(methylsulfonyl)azepane
IUPAC Name4-((6-chloropyrazin-2-yl)methyl)-1-(methylsulfonyl)azepane
MDL No.MFCD19691637
Molecular FormulaC12H18ClN3O2S
Molecular Weight303.82
SMILESO=S(N1CCC(CC2=NC(Cl)=CN=C2)CCC1)(C)=O
InChI KeyATNKSXYYHGMRDU-UHFFFAOYSA-N
Synonym4-(6-Chloro-pyrazin-2-ylmethyl)-1-methanesulfonyl-azepane;1H-Azepine, 4-[(6-chloro-2-pyrazinyl)methyl]hexahydro-1-(methylsulfonyl)-
CAS No.1316222-91-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQQMC199 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAGNO847 route compound structure diagram
    ACAGNO847916791-07-6In Stock
  4. Then
  5. ACQQMC199 route product structure diagram
    ACQQMC1991316222-91-9
Inquiry

2. ACQQMC199 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQQMC199 route product structure diagram
    ACQQMC1991316222-91-9
Inquiry

3. ACQQMC199 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQQMC199 route product structure diagram
    ACQQMC1991316222-91-9
Inquiry

Comments (0)